| 词条 | BioCryst Pharmaceuticals |
| 释义 |
| name = BioCryst Pharmaceuticals, Inc. | logo = BioCryst Logo.gif | type = Public | traded_as = {{NASDAQ|BCRX}} Russell 2000 Component | foundation = 1986 | location = Durham, North Carolina, USA | key_people = Jon P. Stonehouse , President and Chief Executive Officer Thomas Staab II, Chief Financial Officer | industry = Healthcare | products = Biotechnology | revenue = {{profit}}US$26.3M (FY 2012)[1] | operating_income = {{loss}}US$-33.9M (FY 2012)[1] | net_income = {{loss}}US$-39.1M (FY 2012)[1] | assets = {{decrease}}US$57.4M (FY 2012)[2] | equity = {{decrease}}US$-0.4M (FY 2012)[2] | num_employees = 37 (2013) | slogan = | homepage = www.biocryst.com }} BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina.[3] The company focuses on orphan & autoimmune diseases, and antivirals.[3] The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1[4] pandemic. HistoryThe company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. In March 1994, BioCryst became a public company when it completed an Initial Public Offering by listing its shares on the NASDAQ stock exchange. In 2008 the company was named one of the fastest growing companies by Deloitte & Touche in its 2008 list of Technology Fast 500.[5] In October 2010, BioCryst announced its headquarters would move to Durham, North Carolina, where the company has had an office since 2006.[6] BioCryst is a member of the Alliance for Biosecurity, a group of companies that work to develop vaccines and other measures that can be used in the case of a pandemic or bioterrorism attack.[7][8] Pipeline
References1. ^1 2 BioCryst Pharmaceuticals (BCRX) annual SEC income statement filing via Wikinvest. 2. ^1 BioCryst Pharmaceuticals (BCRX) annual SEC balance sheet filing via Wikinvest. 3. ^1 {{cite web |url=http://www.biocryst.com/about_biocryst|title=BioCryst Pharmaceuticals |accessdate=September 26, 2013 |quote= |publisher=BioCryst Pharmaceuticals }} 4. ^{{cite web|url=https://www.cdc.gov/h1n1flu/eua/EUA%20Peramivir%20Letter%20-%20Frieden.pdf |title=Emergency use authorization for the unapproved drug Peramivir |accessdate=October 28, 2009 |quote= |publisher=U.S. Centers for Disease Control and Prevention |deadurl=yes |archiveurl=https://web.archive.org/web/20091122142722/http://www.cdc.gov/h1n1flu/eua/EUA%20Peramivir%20Letter%20-%20Frieden.pdf |archivedate=November 22, 2009 }} 5. ^BioCryst named 29th fastest growing tech firm Birmingham Business Journal, November 26, 2008 6. ^{{cite news|url=http://www.newsobserver.com/2010/10/14/739369/biocryst-moving-hq-to-durham.html|title=BioCryst moving HQ to Durham|last=Ranii|first=David|work=News & Observer|date=October 14, 2010|accessdate=October 14, 2010|deadurl=yes|archiveurl=https://web.archive.org/web/20101017043235/http://www.newsobserver.com/2010/10/14/739369/biocryst-moving-hq-to-durham.html|archivedate=October 17, 2010|df=mdy-all}} 7. ^{{Cite web|url=https://www.allianceforbiosecurity.org/contact|title=Our Members|last=|first=|date=|website=Alliance for Biosecurity|publisher=|access-date=2017-02-02}}{{Dead link|date=November 2018 |bot=InternetArchiveBot |fix-attempted=yes }} 8. ^{{Cite web|url=https://www.allianceforbiosecurity.org/mission|title=Our Mission|last=|first=|date=|website=Alliance for Biosecurity|publisher=|access-date=2017-02-02}}{{Dead link|date=November 2018 |bot=InternetArchiveBot |fix-attempted=yes }} External links
5 : Pharmaceutical companies of the United States|Pharmaceutical companies established in 1986|Health care companies based in North Carolina|Companies listed on NASDAQ|Life sciences industry |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。